by Patrick Appel


Robert Reich is frets about what Obama had to do to get the pharma industry to support health care reform:

[T]he deal between Big Pharma and the White House frankly worries me. It's bad enough when industry lobbyists extract concessions from members of Congress, which happens all the time. But when an industry gets secret concessions out of the White House in return for a promise to lend the industry's support to a key piece of legislation, we're in big trouble. That's called extortion: An industry is using its capacity to threaten or prevent legislation as a means of altering that legislation for its own benefit. And it's doing so at the highest reaches of our government, in the office of the President.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.